We demonstrate that administration of the PVAX through local injection followed by NIR laser-triggered activation efficiently prevent postoperative tumor recurrence and metastasis by simultaneously boosting patient-specific immune responses and blocking PD-L1-dependent immune evasion. The gene discussed is CD274; the disease is neoplasm.